共 50 条
- [32] Phase Ib/II study of BCL-2 inhibitor lisaftoclax (APG-2575) safety and tolerability when administered alone or combined with a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor in patients with estrogen receptor-positive (ER plus ) breast cancer or advanced solid tumors JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
- [36] A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors Investigational New Drugs, 2021, 39 : 1036 - 1046